PDL BioPharma Shares Outstanding 2006-2019 | PDLI

PDL BioPharma shares outstanding from 2006 to 2019. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
PDL BioPharma Annual Shares Outstanding
(Millions of Shares)
2018 146
2017 156
2016 164
2015 164
2014 173
2013 159
2012 146
2011 177
2010 179
2009 184
2008 168
2007 141
2006 140
2005 104
PDL BioPharma Quarterly Shares Outstanding
(Millions of Shares)
Q3 2019 113
Q2 2019 118
Q1 2019 129
Q4 2018 146
Q3 2018 144
Q2 2018 147
Q1 2018 153
Q4 2017 156
Q3 2017 152
Q2 2017 156
Q1 2017 164
Q4 2016 164
Q3 2016 164
Q2 2016 164
Q1 2016 164
Q4 2015 164
Q3 2015 164
Q2 2015 165
Q1 2015 170
Q4 2014 173
Q3 2014 167
Q2 2014 177
Q1 2014 165
Q4 2013 159
Q3 2013 155
Q2 2013 152
Q1 2013 149
Q4 2012 146
Q3 2012 150
Q2 2012 142
Q1 2012 140
Q4 2011 177
Q3 2011 167
Q2 2011 186
Q1 2011 190
Q4 2010 179
Q3 2010 172
Q2 2010 173
Q1 2010 184
Q4 2009 184
Q3 2009 169
Q2 2009 170
Q1 2009 173
Q4 2008 168
Q3 2008 153
Q2 2008 152
Q1 2008 141
Q4 2007 117
Q3 2007 117
Q2 2007 120
Q1 2007 118
Q4 2006 114
Q3 2006 114
Q2 2006 114
Q1 2006 112
Q4 2005 112
Q3 2005 105
Q2 2005 104
Q1 2005 97
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.341B $0.198B
Protein Design Labs Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a leader in the development of humanized antibodies, PDL has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $138.688B 15.98
CSL (CSLLY) Australia $86.180B 0.00
Gilead Sciences (GILD) United States $83.411B 10.33
Vertex Pharmaceuticals (VRTX) United States $57.362B 58.55
Biogen (BIIB) United States $54.022B 9.27
Illumina (ILMN) United States $47.012B 51.58
Regeneron Pharmaceuticals (REGN) United States $40.442B 17.71
Alexion Pharmaceuticals (ALXN) United States $23.771B 11.74
Incyte (INCY) United States $20.245B 46.99
Seattle Genetics (SGEN) United States $20.080B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $17.057B 0.00
Genmab (GNMSF) Denmark $14.761B 65.20
BioMarin Pharmaceutical (BMRN) United States $14.384B 0.00
Alnylam Pharmaceuticals (ALNY) United States $13.850B 0.00
Galapagos (GLPG) Belgium $11.489B 29.60
Exact Sciences (EXAS) United States $10.855B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.393B 49.88
QIAGEN (QGEN) Netherlands $9.422B 30.72
BeiGene (BGNE) Cayman Islands $9.086B 0.00
Bio-Techne Corp (TECH) United States $8.300B 55.55
Sarepta Therapeutics (SRPT) United States $8.197B 0.00
Amarin (AMRN) Ireland $7.791B 0.00
ACADIA Pharmaceuticals (ACAD) United States $7.775B 0.00
Guardant Health (GH) United States $6.910B 0.00
Moderna (MRNA) United States $6.878B 0.00
Medicines (MDCO) United States $6.689B 0.00
Reata Pharmaceuticals (RETA) United States $6.041B 0.00
Horizon Therapeutics Public (HZNP) Ireland $5.967B 15.17
ARGENX SE-ADR (ARGX) Netherlands $5.702B 0.00
Exelixis (EXEL) United States $5.211B 14.66
BioNTech SE (BNTX) Germany $5.089B 0.00
Ascendis Pharma (ASND) Denmark $4.626B 0.00
Repligen (RGEN) United States $4.603B 83.42
China Biologic Products (CBPO) China $4.590B 25.86
Bluebird Bio (BLUE) United States $4.462B 0.00
Spark Therapeutics (ONCE) United States $4.225B 0.00
Mirati Therapeutics (MRTX) United States $4.133B 0.00
MorphoSys AG (MOR) Germany $4.095B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.921B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.903B 0.00
Blueprint Medicines (BPMC) United States $3.669B 0.00
Adaptive Biotechnologies (ADPT) United States $3.649B 0.00
Immunomedics (IMMU) United States $3.577B 0.00
Alkermes (ALKS) Ireland $3.253B 0.00
Genmab (GMAB) Denmark $3.105B 6.40
MyoKardia (MYOK) United States $3.103B 0.00
UniQure (QURE) Netherlands $2.817B 0.00
Halozyme Therapeutics (HALO) United States $2.793B 0.00
NeoGenomics (NEO) United States $2.722B 144.83
Emergent Biosolutions (EBS) United States $2.714B 26.96
Acceleron Pharma (XLRN) United States $2.584B 0.00
Amicus Therapeutics (FOLD) United States $2.553B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.472B 0.00
Zai Lab (ZLAB) China $2.392B 0.00
Arena Pharmaceuticals (ARNA) United States $2.330B 5.42
RA PHARMCTL INC (RARX) United States $2.208B 0.00
Insmed (INSM) United States $2.016B 0.00
Myriad Genetics (MYGN) United States $1.910B 28.21
Ligand Pharmaceuticals (LGND) United States $1.843B 35.45
Dicerna Pharmaceuticals (DRNA) United States $1.814B 0.00
Denali Therapeutics (DNLI) United States $1.746B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.667B 0.00
Akcea Therapeutics (AKCA) United States $1.654B 0.00
Zymeworks (ZYME) Canada $1.651B 0.00
REGENXBIO (RGNX) United States $1.602B 0.00
Editas Medicine (EDIT) United States $1.559B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.465B 0.00
Epizyme (EPZM) United States $1.393B 0.00
Sangamo Therapeutics (SGMO) United States $1.344B 0.00
Alector (ALEC) United States $1.336B 0.00
Innoviva (INVA) United States $1.314B 3.87
Arvinas (ARVN) United States $1.274B 0.00
Athenex (ATNX) United States $1.274B 0.00
Coherus BioSciences (CHRS) United States $1.232B 0.00
Principia Biopharma (PRNB) United States $1.193B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
WAVE Life Sciences (WVE) Singapore $1.114B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.104B 0.00
Fate Therapeutics (FATE) United States $1.026B 0.00
Zealand Pharma (ZEAL) Denmark $0.988B 0.00
Precision BioSciences (DTIL) United States $0.940B 0.00
Pharming Group (PHGUF) Netherlands $0.926B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.921B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.913B 7.67
Codexis (CDXS) United States $0.896B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.861B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.846B 0.00
Intellia Therapeutics (NTLA) United States $0.842B 0.00
Vericel (VCEL) United States $0.820B 305.83
MiMedx (MDXG) United States $0.818B 0.00
Anika Therapeutics (ANIK) United States $0.814B 26.41
Twist Bioscience (TWST) United States $0.767B 0.00
Heska (HSKA) United States $0.739B 188.92
Revance Therapeutics (RVNC) United States $0.719B 0.00
DBV Technologies S.A (DBVT) France $0.712B 0.00
ANI Pharmaceuticals (ANIP) United States $0.710B 12.10
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Cara Therapeutics (CARA) United States $0.646B 0.00
UROGEN PHARMA (URGN) United States $0.642B 0.00
Cellectis S.A (CLLS) France $0.618B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.593B 0.00
GENFIT S.A (GNFT) France $0.592B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
BioDelivery Sciences (BDSI) United States $0.581B 0.00
Cytokineticsorporated (CYTK) United States $0.580B 0.00
PHARMA MAR SA (PHMMF) Spain $0.564B 0.00
Agenus (AGEN) United States $0.559B 0.00
Retrophin (RTRX) United States $0.555B 0.00
AC Immune SA (ACIU) Switzerland $0.553B 12.80
Intra-Cellular Therapies (ITCI) United States $0.542B 0.00
Sorrento Therapeutics (SRNE) United States $0.536B 0.00
Kadmon Holdings (KDMN) United States $0.530B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.514B 0.00
Prothena (PRTA) Ireland $0.495B 0.00
Stemline Therapeutics (STML) United States $0.492B 0.00
Clovis Oncology (CLVS) United States $0.486B 0.00
Dynavax Technologies (DVAX) United States $0.477B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.450B 3.11
Merus (MRUS) Netherlands $0.390B 0.00
AnaptysBio (ANAB) United States $0.386B 0.00
Bellus Health (BLU) Canada $0.384B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.363B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.359B 0.00
Arcus Biosciences (RCUS) United States $0.357B 0.00
Starpharma Holdings (SPHRY) Australia $0.343B 0.00
OSMOTICA PHARM (OSMT) United States $0.339B 0.00
Pfenex (PFNX) United States $0.336B 0.00
Cellular Biomedicine (CBMG) United States $0.336B 0.00
Avid Bioservices (CDMO) United States $0.318B 0.00
Geron (GERN) United States $0.304B 0.00
Gritstone Oncology (GRTS) United States $0.301B 0.00
Kamada (KMDA) Israel $0.298B 8.71
Kindred Biosciences (KIN) United States $0.297B 0.00
Puma Biotechnology (PBYI) United States $0.290B 0.00
CytomX Therapeutics (CTMX) United States $0.279B 0.00
Compugen (CGEN) Israel $0.276B 0.00
Albireo Pharma (ALBO) United States $0.271B 0.00
Cel-Sci (CVM) United States $0.270B 0.00
Cue Biopharma (CUE) United States $0.261B 0.00
Seres Therapeutics (MCRB) United States $0.258B 0.00
MannKind (MNKD) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.245B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.239B 0.00
Scholar Rock Holding (SRRK) United States $0.237B 0.00
Inovio Pharmaceuticals (INO) United States $0.233B 0.00
Sutro Biopharma (STRO) United States $0.231B 0.00
Senesco Technologies (ELOX) United States $0.229B 0.00
Biofrontera AG (BFRA) Germany $0.226B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.224B 0.00
ChromaDex (CDXC) United States $0.223B 0.00
Spero Therapeutics (SPRO) United States $0.219B 0.00
Theratechnologies (THTX) Canada $0.218B 0.00
Exicure (XCUR) United States $0.216B 0.00
XOMA (XOMA) United States $0.213B 0.00
Protagonist Therapeutics (PTGX) United States $0.208B 0.00
Athersys (ATHX) United States $0.204B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.197B 0.00
Proteostasis Therapeutics (PTI) United States $0.194B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.189B 0.00
Palatin Technologies (PTN) United States $0.181B 4.95
IVERIC Bio (ISEE) United States $0.179B 0.00
Affimed (AFMD) Germany $0.176B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.170B 0.00
ARAVIVE, INC (ARAV) United States $0.168B 0.00
Dyadic (DYAI) United States $0.162B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.159B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.159B 0.00
CorMedix Inc (CRMD) United States $0.157B 0.00
Fortress Biotech (FBIO) United States $0.151B 0.00
Cerecor (CERC) United States $0.149B 0.00
Alcobra (ARCT) United States $0.149B 0.00
NantKwest (NK) United States $0.148B 0.00
VBI Vaccines (VBIV) United States $0.144B 0.00
Abeona Therapeutics (ABEO) United States $0.141B 0.00
Five Prime Therapeutics (FPRX) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arsanis (XFOR) United States $0.133B 0.00
TELA Bio (TELA) United States $0.133B 0.00
Prometic Life Sciences (LMNL) Canada $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.130B 0.00
Windtree Therapeutics (WINT) United States $0.129B 0.00
Enzo Biochem (ENZ) United States $0.127B 0.00
Arbutus Biopharma (ABUS) Canada $0.126B 0.00
SESEN BIO, INC (SESN) United States $0.126B 0.00
Nicox SA (NICXF) France $0.124B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.123B 0.00
Novavax (NVAX) United States $0.121B 0.00
BioTime (LCTX) United States $0.120B 6.15
Adaptimmune Therapeutics (ADAP) United Kingdom $0.119B 0.00
Celyad SA (CYAD) Belgium $0.119B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.100B 0.00
Menlo Therapeutics (MNLO) United States $0.099B 0.00
Emmaus Life Sciences (EMMA) United States $0.096B 0.00
Strongbridge Biopharma (SBBP) United States $0.096B 2.57
Aduro Biotech (ADRO) United States $0.095B 0.00
Verastem (VSTM) United States $0.093B 0.00
PHASEBIO PHARMA (PHAS) United States $0.093B 0.00
Adocia (ADOCY) France $0.086B 0.00
Antibe Therapeutics (ATBPF) Canada $0.084B 0.00
Acorda Therapeutics (ACOR) United States $0.082B 0.00
VTv Therapeutics (VTVT) United States $0.081B 0.00
OvaScience (MLND) United States $0.081B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.080B 0.00
Liquidia Technologies (LQDA) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.072B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.069B 0.00
Clearside Biomedical (CLSD) United States $0.067B 0.00
Trevena (TRVN) United States $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Organovo Holdings (ONVO) United States $0.064B 0.00
Curis (CRIS) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.061B 0.00
Pluristem Therapeutics (PSTI) Israel $0.059B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.058B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.057B 0.00
Applied Genetic Technologies (AGTC) United States $0.054B 0.00
Idera Pharmaceuticals (IDRA) United States $0.051B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.047B 0.00
AquaBounty Technologies (AQB) United States $0.046B 0.00
Checkpoint Therapeutics (CKPT) United States $0.046B 0.00
AIT Therapeutics (XAIR) United States $0.045B 0.00
Protalix BioTherapeutics (PLX) Israel $0.045B 0.00
Vascular Biogenics (VBLT) Israel $0.045B 0.00
Orgenesis (ORGS) United States $0.042B 2.72
Celldex Therapeutics (CLDX) United States $0.041B 0.00
AmpliPhi Biosciences (ARMP) United States $0.041B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.039B 0.00
DiaMedica Therapeutics (DMAC) United States $0.035B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.035B 0.00
Alimera Sciences (ALIM) United States $0.034B 0.00
Evogene (EVGN) Israel $0.033B 0.00
Celsion (CLSN) United States $0.033B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.61
Bionano Genomics (BNGO) United States $0.029B 0.00
BioCardia (BCDA) United States $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.026B 0.00
Apricus Biosciences (SEEL) United States $0.026B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.024B 0.00
Entera Bio (ENTX) Israel $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.022B 0.00
Soligenix (SNGX) United States $0.022B 0.00
Unum Therapeutics (UMRX) United States $0.021B 0.00
Signal Genetics (MGEN) United States $0.019B 0.00
CollPlant Holdings (CLGN) Israel $0.019B 0.00
VistaGen Therapeutics (VTGN) United States $0.019B 0.00
AEterna Zentaris (AEZS) United States $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Aytu Bioscience (AYTU) United States $0.017B 0.00
TOCAGEN INC (TOCA) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
MYOS RENS Technology (MYOS) United States $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.013B 0.00
Advaxis (ADXS) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.010B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
IBio (IBIO) United States $0.009B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Genetic Technologies (GENE) Australia $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.007B 0.00
BioPharmX (BPMX) United States $0.006B 0.00
Neuralstem (SNCA) United States $0.004B 0.00